HEADER FLUORESCENT PROTEIN 07-FEB-07 2OTE TITLE CRYSTAL STRUCTURE OF A MONOMERIC CYAN FLUORESCENT PROTEIN IN THE TITLE 2 PHOTOBLEACHED STATE COMPND MOL_ID: 1; COMPND 2 MOLECULE: GFP-LIKE FLUORESCENT CHROMOPROTEIN CFP484; COMPND 3 CHAIN: A, B; COMPND 4 ENGINEERED: YES; COMPND 5 MUTATION: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: CLAVULARIA SP.; SOURCE 3 ORGANISM_TAXID: 86521; SOURCE 4 GENE: CFP484; SOURCE 5 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 6 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 7 EXPRESSION_SYSTEM_STRAIN: TOP10; SOURCE 8 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 9 EXPRESSION_SYSTEM_PLASMID: PBAD/HISB KEYWDS BETA CAN, FLUORESCENT PROTEIN EXPDTA X-RAY DIFFRACTION AUTHOR J.N.HENDERSON,H.AI,R.E.CAMPBELL,S.J.REMINGTON REVDAT 5 18-OCT-17 2OTE 1 REMARK REVDAT 4 22-FEB-12 2OTE 1 SEQRES SEQADV HET HETATM REVDAT 4 2 1 HETNAM LINK REMARK MODRES REVDAT 4 3 1 VERSN REVDAT 3 24-FEB-09 2OTE 1 VERSN REVDAT 2 08-MAY-07 2OTE 1 JRNL REVDAT 1 03-APR-07 2OTE 0 JRNL AUTH J.N.HENDERSON,H.W.AI,R.E.CAMPBELL,S.J.REMINGTON JRNL TITL STRUCTURAL BASIS FOR REVERSIBLE PHOTOBLEACHING OF A GREEN JRNL TITL 2 FLUORESCENT PROTEIN HOMOLOGUE. JRNL REF PROC.NATL.ACAD.SCI.USA V. 104 6672 2007 JRNL REFN ISSN 0027-8424 JRNL PMID 17420458 JRNL DOI 10.1073/PNAS.0700059104 REMARK 2 REMARK 2 RESOLUTION. 1.47 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : SHELX REMARK 3 AUTHORS : G.M.SHELDRICK REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.47 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 10.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : 2.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 94.7 REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (NO CUTOFF). REMARK 3 R VALUE (WORKING + TEST SET, NO CUTOFF) : NULL REMARK 3 R VALUE (WORKING SET, NO CUTOFF) : 0.192 REMARK 3 FREE R VALUE (NO CUTOFF) : 0.261 REMARK 3 FREE R VALUE TEST SET SIZE (%, NO CUTOFF) : NULL REMARK 3 FREE R VALUE TEST SET COUNT (NO CUTOFF) : 3426 REMARK 3 TOTAL NUMBER OF REFLECTIONS (NO CUTOFF) : 68960 REMARK 3 REMARK 3 FIT/AGREEMENT OF MODEL FOR DATA WITH F>4SIG(F). REMARK 3 R VALUE (WORKING + TEST SET, F>4SIG(F)) : NULL REMARK 3 R VALUE (WORKING SET, F>4SIG(F)) : NULL REMARK 3 FREE R VALUE (F>4SIG(F)) : NULL REMARK 3 FREE R VALUE TEST SET SIZE (%, F>4SIG(F)) : NULL REMARK 3 FREE R VALUE TEST SET COUNT (F>4SIG(F)) : NULL REMARK 3 TOTAL NUMBER OF REFLECTIONS (F>4SIG(F)) : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 3433 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 4 REMARK 3 SOLVENT ATOMS : 450 REMARK 3 REMARK 3 MODEL REFINEMENT. REMARK 3 OCCUPANCY SUM OF NON-HYDROGEN ATOMS : NULL REMARK 3 OCCUPANCY SUM OF HYDROGEN ATOMS : NULL REMARK 3 NUMBER OF DISCRETELY DISORDERED RESIDUES : NULL REMARK 3 NUMBER OF LEAST-SQUARES PARAMETERS : NULL REMARK 3 NUMBER OF RESTRAINTS : NULL REMARK 3 REMARK 3 RMS DEVIATIONS FROM RESTRAINT TARGET VALUES. REMARK 3 BOND LENGTHS (A) : 0.009 REMARK 3 ANGLE DISTANCES (A) : 0.029 REMARK 3 SIMILAR DISTANCES (NO TARGET VALUES) (A) : NULL REMARK 3 DISTANCES FROM RESTRAINT PLANES (A) : NULL REMARK 3 ZERO CHIRAL VOLUMES (A**3) : NULL REMARK 3 NON-ZERO CHIRAL VOLUMES (A**3) : NULL REMARK 3 ANTI-BUMPING DISTANCE RESTRAINTS (A) : NULL REMARK 3 RIGID-BOND ADP COMPONENTS (A**2) : NULL REMARK 3 SIMILAR ADP COMPONENTS (A**2) : NULL REMARK 3 APPROXIMATELY ISOTROPIC ADPS (A**2) : NULL REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED: NULL REMARK 3 REMARK 3 STEREOCHEMISTRY TARGET VALUES : ENGH & HUBER REMARK 3 SPECIAL CASE: NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 2OTE COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 08-FEB-07. REMARK 100 THE DEPOSITION ID IS D_1000041561. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 17-JUN-06 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 4.8 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : APS REMARK 200 BEAMLINE : 14-BM-C REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.9 REMARK 200 MONOCHROMATOR : BENT GE(111) MONOCHROMATOR REMARK 200 OPTICS : BENT CONICAL SI-MIRROR (RH REMARK 200 COATED) REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 315 REMARK 200 INTENSITY-INTEGRATION SOFTWARE : DENZO, HKL-2000 REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 68960 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.470 REMARK 200 RESOLUTION RANGE LOW (A) : 50.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : -3.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 94.7 REMARK 200 DATA REDUNDANCY : 3.500 REMARK 200 R MERGE (I) : 0.05400 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 16.4000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.47 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.52 REMARK 200 COMPLETENESS FOR SHELL (%) : 91.2 REMARK 200 DATA REDUNDANCY IN SHELL : 3.50 REMARK 200 R MERGE FOR SHELL (I) : 0.44900 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 2.400 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: EPMR 2.5 REMARK 200 STARTING MODEL: PDB ENTRY 2OTB WITH THE WATERS AND CHROMOPHORES REMARK 200 REMOVED. REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 42.16 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.13 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 31% PEG 3400, 0.2 M LITHIUM SULFATE, REMARK 280 0.1 M SODIUM ACETATE, 2.9 MM 1-S-NONYL-BETA-D-THIOGLUCOSIDE, PH REMARK 280 4.8, VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 295K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 32.74450 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 48.60150 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 33.15500 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 48.60150 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 32.74450 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 33.15500 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 300 REMARK: THE BIOLOGICAL ASSEMBLY IS A MONOMER. THERE ARE TWO REMARK 300 MONOMERS PER ASYMMETRIC UNIT. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 LYS A 9 CE NZ REMARK 470 LYS A 13 NZ REMARK 470 LYS A 15 CD CE NZ REMARK 470 LYS A 17 NZ REMARK 470 GLU A 19 CD OE1 OE2 REMARK 470 GLU A 32 CD OE1 OE2 REMARK 470 LYS A 36 CD CE NZ REMARK 470 LYS A 74 CE NZ REMARK 470 LYS A 102 CE NZ REMARK 470 LYS A 106 CD CE NZ REMARK 470 LYS A 108 CE NZ REMARK 470 GLU A 121 CG CD OE1 OE2 REMARK 470 LYS A 125 CD CE NZ REMARK 470 LYS A 138 CE NZ REMARK 470 LYS A 139 CD CE NZ REMARK 470 LYS A 164 NZ REMARK 470 ARG A 174 NE CZ NH1 NH2 REMARK 470 LYS A 188 NZ REMARK 470 LYS A 206 CD CE NZ REMARK 470 LYS B 15 CD CE NZ REMARK 470 LYS B 17 CE NZ REMARK 470 LYS B 36 CD CE NZ REMARK 470 LYS B 74 CE NZ REMARK 470 LYS B 102 CG CD CE NZ REMARK 470 LYS B 138 NZ REMARK 470 ARG B 198 CZ NH1 NH2 REMARK 470 LYS B 206 CG CD CE NZ REMARK 470 LYS B 210 NZ REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 PHE A 118 CB - CG - CD2 ANGL. DEV. = -4.9 DEGREES REMARK 500 HIS A 173 CA - CB - CG ANGL. DEV. = 13.0 DEGREES REMARK 500 ARG A 182 CD - NE - CZ ANGL. DEV. = 11.4 DEGREES REMARK 500 ARG A 182 NE - CZ - NH1 ANGL. DEV. = 3.2 DEGREES REMARK 500 ARG A 220 NE - CZ - NH2 ANGL. DEV. = -5.3 DEGREES REMARK 500 ARG B 70 NE - CZ - NH2 ANGL. DEV. = 3.5 DEGREES REMARK 500 ASP B 101 CB - CG - OD1 ANGL. DEV. = 6.3 DEGREES REMARK 500 ARG B 153 CD - NE - CZ ANGL. DEV. = 8.8 DEGREES REMARK 500 ARG B 182 CD - NE - CZ ANGL. DEV. = 27.3 DEGREES REMARK 500 ARG B 182 NE - CZ - NH1 ANGL. DEV. = 6.3 DEGREES REMARK 500 ARG B 220 NE - CZ - NH1 ANGL. DEV. = 3.3 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 PRO A 55 31.53 -89.06 REMARK 500 ARG A 70 0.42 -66.54 REMARK 500 LYS A 102 -4.96 87.83 REMARK 500 GLU A 115 -124.09 48.03 REMARK 500 ASP A 116 39.01 -96.23 REMARK 500 ARG B 70 0.31 -66.06 REMARK 500 PHE B 72 56.64 -95.13 REMARK 500 LYS B 102 -5.04 82.68 REMARK 500 GLU B 115 -129.44 51.04 REMARK 500 ASP B 116 41.81 -91.84 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE ACT A 1 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 2OTB RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF A MONOMERIC CYAN FLUORESCENT PROTEIN IN THE REMARK 900 FLUORESCENT STATE DBREF 2OTE A 6 221 UNP Q9U6Y3 GFPL_CLASP 44 259 DBREF 2OTE B 6 221 UNP Q9U6Y3 GFPL_CLASP 44 259 SEQADV 2OTE ASN A 42 UNP Q9U6Y3 HIS 80 ENGINEERED MUTATION SEQADV 2OTE ILE A 44 UNP Q9U6Y3 LEU 82 ENGINEERED MUTATION SEQADV 2OTE THR A 62 UNP Q9U6Y3 SER 100 ENGINEERED MUTATION SEQADV 2OTE PIA A 66 UNP Q9U6Y3 GLN 104 CHROMOPHORE SEQADV 2OTE PIA A 66 UNP Q9U6Y3 TYR 105 CHROMOPHORE SEQADV 2OTE PIA A 66 UNP Q9U6Y3 GLY 106 CHROMOPHORE SEQADV 2OTE PHE A 72 UNP Q9U6Y3 LEU 110 ENGINEERED MUTATION SEQADV 2OTE PRO A 80 UNP Q9U6Y3 ALA 118 ENGINEERED MUTATION SEQADV 2OTE ASN A 81 UNP Q9U6Y3 ASP 119 ENGINEERED MUTATION SEQADV 2OTE HIS A 123 UNP Q9U6Y3 ARG 161 ENGINEERED MUTATION SEQADV 2OTE LEU A 124 UNP Q9U6Y3 PHE 162 ENGINEERED MUTATION SEQADV 2OTE LYS A 125 UNP Q9U6Y3 ASP 163 ENGINEERED MUTATION SEQADV 2OTE GLU A 127 UNP Q9U6Y3 MET 165 ENGINEERED MUTATION SEQADV 2OTE LEU A 150 UNP Q9U6Y3 MET 188 ENGINEERED MUTATION SEQADV 2OTE LYS A 162 UNP Q9U6Y3 SER 200 ENGINEERED MUTATION SEQADV 2OTE LYS A 164 UNP Q9U6Y3 SER 202 ENGINEERED MUTATION SEQADV 2OTE HIS A 173 UNP Q9U6Y3 TYR 211 ENGINEERED MUTATION SEQADV 2OTE VAL A 175 UNP Q9U6Y3 CYS 213 ENGINEERED MUTATION SEQADV 2OTE THR A 179 UNP Q9U6Y3 SER 217 ENGINEERED MUTATION SEQADV 2OTE ARG A 182 UNP Q9U6Y3 LYS 220 ENGINEERED MUTATION SEQADV 2OTE ALA A 186 UNP Q9U6Y3 VAL 224 ENGINEERED MUTATION SEQADV 2OTE VAL A 213 UNP Q9U6Y3 LEU 251 ENGINEERED MUTATION SEQADV 2OTE SER A 216 UNP Q9U6Y3 ASN 254 ENGINEERED MUTATION SEQADV 2OTE ASN B 42 UNP Q9U6Y3 HIS 80 ENGINEERED MUTATION SEQADV 2OTE ILE B 44 UNP Q9U6Y3 LEU 82 ENGINEERED MUTATION SEQADV 2OTE THR B 62 UNP Q9U6Y3 SER 100 ENGINEERED MUTATION SEQADV 2OTE PIA B 66 UNP Q9U6Y3 GLN 104 CHROMOPHORE SEQADV 2OTE PIA B 66 UNP Q9U6Y3 TYR 105 CHROMOPHORE SEQADV 2OTE PIA B 66 UNP Q9U6Y3 GLY 106 CHROMOPHORE SEQADV 2OTE PHE B 72 UNP Q9U6Y3 LEU 110 ENGINEERED MUTATION SEQADV 2OTE PRO B 80 UNP Q9U6Y3 ALA 118 ENGINEERED MUTATION SEQADV 2OTE ASN B 81 UNP Q9U6Y3 ASP 119 ENGINEERED MUTATION SEQADV 2OTE HIS B 123 UNP Q9U6Y3 ARG 161 ENGINEERED MUTATION SEQADV 2OTE LEU B 124 UNP Q9U6Y3 PHE 162 ENGINEERED MUTATION SEQADV 2OTE LYS B 125 UNP Q9U6Y3 ASP 163 ENGINEERED MUTATION SEQADV 2OTE GLU B 127 UNP Q9U6Y3 MET 165 ENGINEERED MUTATION SEQADV 2OTE LEU B 150 UNP Q9U6Y3 MET 188 ENGINEERED MUTATION SEQADV 2OTE LYS B 162 UNP Q9U6Y3 SER 200 ENGINEERED MUTATION SEQADV 2OTE LYS B 164 UNP Q9U6Y3 SER 202 ENGINEERED MUTATION SEQADV 2OTE HIS B 173 UNP Q9U6Y3 TYR 211 ENGINEERED MUTATION SEQADV 2OTE VAL B 175 UNP Q9U6Y3 CYS 213 ENGINEERED MUTATION SEQADV 2OTE THR B 179 UNP Q9U6Y3 SER 217 ENGINEERED MUTATION SEQADV 2OTE ARG B 182 UNP Q9U6Y3 LYS 220 ENGINEERED MUTATION SEQADV 2OTE ALA B 186 UNP Q9U6Y3 VAL 224 ENGINEERED MUTATION SEQADV 2OTE VAL B 213 UNP Q9U6Y3 LEU 251 ENGINEERED MUTATION SEQADV 2OTE SER B 216 UNP Q9U6Y3 ASN 254 ENGINEERED MUTATION SEQRES 1 A 214 GLY VAL ILE LYS PRO ASP MET LYS ILE LYS LEU LYS MET SEQRES 2 A 214 GLU GLY ASN VAL ASN GLY HIS ALA PHE VAL ILE GLU GLY SEQRES 3 A 214 GLU GLY GLU GLY LYS PRO TYR ASP GLY THR ASN THR ILE SEQRES 4 A 214 ASN LEU GLU VAL LYS GLU GLY ALA PRO LEU PRO PHE SER SEQRES 5 A 214 TYR ASP ILE LEU THR ASN ALA PHE PIA ASN ARG ALA PHE SEQRES 6 A 214 THR LYS TYR PRO ASP ASP ILE PRO ASN TYR PHE LYS GLN SEQRES 7 A 214 SER PHE PRO GLU GLY TYR SER TRP GLU ARG THR MET THR SEQRES 8 A 214 PHE GLU ASP LYS GLY ILE VAL LYS VAL LYS SER ASP ILE SEQRES 9 A 214 SER MET GLU GLU ASP SER PHE ILE TYR GLU ILE HIS LEU SEQRES 10 A 214 LYS GLY GLU ASN PHE PRO PRO ASN GLY PRO VAL MET GLN SEQRES 11 A 214 LYS LYS THR LEU LYS TRP GLU PRO SER THR GLU ILE LEU SEQRES 12 A 214 TYR VAL ARG ASP GLY VAL LEU VAL GLY ASP ILE LYS HIS SEQRES 13 A 214 LYS LEU LEU LEU GLU GLY GLY GLY HIS HIS ARG VAL ASP SEQRES 14 A 214 PHE LYS THR ILE TYR ARG ALA LYS LYS ALA VAL LYS LEU SEQRES 15 A 214 PRO ASP TYR HIS PHE VAL ASP HIS ARG ILE GLU ILE LEU SEQRES 16 A 214 ASN HIS ASP LYS ASP TYR ASN LYS VAL THR VAL TYR GLU SEQRES 17 A 214 SER ALA VAL ALA ARG TYR SEQRES 1 B 214 GLY VAL ILE LYS PRO ASP MET LYS ILE LYS LEU LYS MET SEQRES 2 B 214 GLU GLY ASN VAL ASN GLY HIS ALA PHE VAL ILE GLU GLY SEQRES 3 B 214 GLU GLY GLU GLY LYS PRO TYR ASP GLY THR ASN THR ILE SEQRES 4 B 214 ASN LEU GLU VAL LYS GLU GLY ALA PRO LEU PRO PHE SER SEQRES 5 B 214 TYR ASP ILE LEU THR ASN ALA PHE PIA ASN ARG ALA PHE SEQRES 6 B 214 THR LYS TYR PRO ASP ASP ILE PRO ASN TYR PHE LYS GLN SEQRES 7 B 214 SER PHE PRO GLU GLY TYR SER TRP GLU ARG THR MET THR SEQRES 8 B 214 PHE GLU ASP LYS GLY ILE VAL LYS VAL LYS SER ASP ILE SEQRES 9 B 214 SER MET GLU GLU ASP SER PHE ILE TYR GLU ILE HIS LEU SEQRES 10 B 214 LYS GLY GLU ASN PHE PRO PRO ASN GLY PRO VAL MET GLN SEQRES 11 B 214 LYS LYS THR LEU LYS TRP GLU PRO SER THR GLU ILE LEU SEQRES 12 B 214 TYR VAL ARG ASP GLY VAL LEU VAL GLY ASP ILE LYS HIS SEQRES 13 B 214 LYS LEU LEU LEU GLU GLY GLY GLY HIS HIS ARG VAL ASP SEQRES 14 B 214 PHE LYS THR ILE TYR ARG ALA LYS LYS ALA VAL LYS LEU SEQRES 15 B 214 PRO ASP TYR HIS PHE VAL ASP HIS ARG ILE GLU ILE LEU SEQRES 16 B 214 ASN HIS ASP LYS ASP TYR ASN LYS VAL THR VAL TYR GLU SEQRES 17 B 214 SER ALA VAL ALA ARG TYR MODRES 2OTE PIA A 66 ALA MODRES 2OTE PIA A 66 TYR MODRES 2OTE PIA A 66 GLY MODRES 2OTE PIA B 66 ALA MODRES 2OTE PIA B 66 TYR MODRES 2OTE PIA B 66 GLY HET PIA A 66 20 HET PIA B 66 20 HET ACT A 1 4 HETNAM PIA [(4Z)-2-[(1S)-1-AMINOETHYL]-4-(4-HYDROXYBENZYLIDENE)-5- HETNAM 2 PIA OXO-4,5-DIHYDRO-1H-IMIDAZOL-1-YL]ACETIC ACID HETNAM ACT ACETATE ION FORMUL 1 PIA 2(C14 H15 N3 O4) FORMUL 3 ACT C2 H3 O2 1- FORMUL 4 HOH *450(H2 O) HELIX 1 1 TYR A 58 ASN A 63 1 6 HELIX 2 2 ASN A 81 SER A 86 1 6 HELIX 3 3 TYR B 58 ASN B 63 1 6 HELIX 4 4 ASN B 81 SER B 86 1 6 SHEET 1 A13 THR A 140 TRP A 143 0 SHEET 2 A13 VAL A 156 LEU A 167 -1 O LEU A 166 N LEU A 141 SHEET 3 A13 HIS A 172 ALA A 183 -1 O TYR A 181 N LEU A 157 SHEET 4 A13 TYR A 91 PHE A 99 -1 N GLU A 94 O ILE A 180 SHEET 5 A13 ILE A 104 GLU A 114 -1 O VAL A 107 N ARG A 95 SHEET 6 A13 SER A 117 GLU A 127 -1 O GLU A 127 N ILE A 104 SHEET 7 A13 MET A 12 VAL A 22 1 N LYS A 17 O ILE A 122 SHEET 8 A13 HIS A 25 LYS A 36 -1 O ILE A 29 N MET A 18 SHEET 9 A13 THR A 41 GLU A 50 -1 O LYS A 49 N VAL A 28 SHEET 10 A13 LYS A 210 ARG A 220 -1 O VAL A 211 N LEU A 46 SHEET 11 A13 HIS A 193 HIS A 204 -1 N GLU A 200 O TYR A 214 SHEET 12 A13 SER A 146 ARG A 153 -1 N GLU A 148 O VAL A 195 SHEET 13 A13 VAL A 156 LEU A 167 -1 O VAL A 158 N TYR A 151 SHEET 1 B13 THR B 140 TRP B 143 0 SHEET 2 B13 VAL B 156 LEU B 167 -1 O LEU B 166 N LEU B 141 SHEET 3 B13 HIS B 172 ALA B 183 -1 O TYR B 181 N LEU B 157 SHEET 4 B13 TYR B 91 PHE B 99 -1 N SER B 92 O ARG B 182 SHEET 5 B13 ILE B 104 GLU B 114 -1 O VAL B 107 N ARG B 95 SHEET 6 B13 SER B 117 GLU B 127 -1 O LYS B 125 N LYS B 106 SHEET 7 B13 MET B 12 VAL B 22 1 N ASN B 21 O GLY B 126 SHEET 8 B13 HIS B 25 LYS B 36 -1 O ILE B 29 N MET B 18 SHEET 9 B13 THR B 41 GLU B 50 -1 O THR B 43 N GLU B 34 SHEET 10 B13 LYS B 210 ARG B 220 -1 O VAL B 211 N LEU B 46 SHEET 11 B13 HIS B 193 HIS B 204 -1 N PHE B 194 O ARG B 220 SHEET 12 B13 SER B 146 ARG B 153 -1 N GLU B 148 O VAL B 195 SHEET 13 B13 VAL B 156 LEU B 167 -1 O VAL B 158 N TYR B 151 LINK C PHE A 65 N1 APIA A 66 1555 1555 1.42 LINK C3 APIA A 66 N ASN A 69 1555 1555 1.28 LINK C PHE B 65 N1 PIA B 66 1555 1555 1.25 LINK C3 APIA B 66 N ASN B 69 1555 1555 1.40 CISPEP 1 ALA A 52 PRO A 53 0 -3.99 CISPEP 2 PHE A 87 PRO A 88 0 7.11 CISPEP 3 ALA B 52 PRO B 53 0 -4.25 CISPEP 4 PHE B 87 PRO B 88 0 7.48 SITE 1 AC1 4 GLY A 33 GLU A 34 THR A 43 ASP B 160 CRYST1 65.489 66.310 97.203 90.00 90.00 90.00 P 21 21 21 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.015270 0.000000 0.000000 0.00000 SCALE2 0.000000 0.015081 0.000000 0.00000 SCALE3 0.000000 0.000000 0.010288 0.00000 MASTER 287 0 3 4 26 0 1 6 0 0 0 34 END